[Socioeconomic aspects of therapy of cardiovascular diseases].
Lauterbach
K W
KW
D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005260:Female; D006292:Health Priorities; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D017035:Pravastatin / Q000191:economics / Q000627:therapeutic use; D011322:Primary Prevention; D011379:Prognosis; D012307:Risk Factors; D012959:Socioeconomic Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D002784:Cholesterol; D017035:Pravastatin